Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease

NCT03762824 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis
Systemic Lupus
Sjögren Syndrome
Systemic Vasculitis
Spondyloarthritis

Interventions

BIOLOGICAL: 13-valent pneumococcal conjugate vaccine
BIOLOGICAL: 23-valent pneumococcal polysaccharide vaccine

Sponsor

Region Skane